NCT02929901View on ClinicalTrials.gov

The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

March 31, 2019

Conditions

Type 2 Diabetes Nonalcoholic Fatty Liver

Interventions

DIETARY_SUPPLEMENT

caffeine and chlorogenic acid

caffeine plus chlorogenic acid

DIETARY_SUPPLEMENT

caffeine

caffeine plus placebo

DIETARY_SUPPLEMENT

chlorogenic acid

chlorogenic acid plus placebo

DIETARY_SUPPLEMENT

placebo

placebo plus placebo

Trial Locations (1)

19435

NNFTRI clinic, Tehran

All Listed Sponsors

lead

National Nutrition and Food Technology Institute

OTHER

NCT02929901 - The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter